Henry Uppal

Doctor of Osteopathic Medicine,  Mayo Clinic - Rochester 

Location: United States

Consulting Services

Admin and Customer Support Journal Manuscript Sales and Marketing Scientific Writing

Areas Of Interest

Kytril Family Medical History Programmed Cell Death 1 Receptor Cartilage Matrix Proteins Alloantigens Cardiotoxic Agents Externa, Capsula Lonicerale Peas, Partridge Psychological Distress TRPA1 Cation Channel Teniposide, (5a alpha,9 alpha(S*))-Isomer Tomography, Spiral Volumetric Computed Psychoanalysis Choreas, Fibrillary Lauric Acid Hydroxylase Dryopteris filix-ma Rapid Eye Movement Sleep Behavior Disorder Pisum Extenders, Physicians' Salivary Acidic Protein 1 Neoplasm DNA Vasculosum, Organum Pancreatin Cuemid Awakenings, Post-Anesthesia Delayed ARRB1 Protein Television Systems, Cellfree Meningoencephalitis, Primary Amebic Vesicoureteral Reflux 1 Nursing, Church Translation, Genetic Auriculotemporal Nerve Injuries Trypanosomiasis, American Volumes, Cell Nuclear Process, Dental Physiological Resource, Secondary Energy

Professional Narrative

Dr. Henry Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Medical Writer, Amgen 2010
Director Medicine, Harvard Med 1996

Education

Doctor of medicine, Harvard Medical School 2015
Director Medicine, Weill Medical College 1992

Referees

Publications

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02